CA 19-9 and Pancreatic Carcinoma, a Revival?

Publisher： Karger

E-ISSN： 2296-5262|30|1-2|12-13

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.1-2, 2007-01, pp. : 12-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Marked Elevation of Serum CA19-9 and Stomach Carcinoma

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 487-488

Karger

Access to resources Recommend Favorite

Preoperative CA 19‐9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 3, 2015-03 ,pp. : 293-298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum HCGβ and CA 72-4 Are Stronger Prognostic Factors than CEA, CA 19-9 and CA 242 in Pancreatic Cancer

By  

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

CA19-9 as a Serum Marker for Poor Prognosis in Urothelial Carcinoma

By  

Urologia Internationalis, Vol. 73, Iss. 4, 2004-12 ,pp. : 357-357

Karger

Access to resources Recommend Favorite

CA19-9 as a Serum Marker for Poor Prognosis in Urothelial Carcinoma

By  

Urologia Internationalis, Vol. 72, Iss. 2, 2004-02 ,pp. : 112-117

Karger

Access to resources Recommend Favorite